Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma

Liver cancer is a life-threatening disease, and its incidence is increasing globally. The most common form of liver cancer is hepatocellular carcinoma (HCC). Approximately half of patients with HCC, especially those at advanced disease stages, receive systemic therapies, including the tyrosine kinas...

Full description

Bibliographic Details
Main Authors: Wanying Shen, Yujie Chen, Pan Lei, Marisela Sheldon, Yutong Sun, Fan Yao, Li Ma
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
hepatocellular carcinoma
immunotherapy
immune checkpoint inhibitors
CAR T cells
resistance
combination immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/20/5013

Internet

https://www.mdpi.com/2072-6694/14/20/5013

Similar Items